Urology

Search results

• Why coronavirus hits men harder: sex hormones offer clues

  William Oh

  3/06/20 → 4/06/20

  2 items of Media coverage

  Press/Media

• 6-month progression is strong survival surrogate in prostate cancer subset: Strongest surrogate marker for overall survival in men with metastatic hormone-sensitive disease.(Prostate Cancer / CLINICAL UPDATES)

  William Oh

  1/06/20

  1 item of Media coverage

  Press/Media

• TURNING ON THE 'OFF SWITCH' IN CANCER CELLS

  Matthew Galsky, & Goutham Narla,

  27/05/20

  1 item of Media coverage

  Press/Media

• Drug Combo Offers Hope Against Advanced Bladder Cancer

  Matthew Galsky,

  14/05/20 → 15/05/20

  6 items of Media coverage

  Press/Media

• Clinical Trial Shows Drug Combo Slows Bladder Cancer

  Matthew Galsky,

  15/05/20

  3 items of Media coverage

  Press/Media

• Atezolizumab Added to Chemo Delays Metastatic Bladder Cancer Progression - Cancer Therapy Advisor

  Matthew Galsky,

  15/05/20

  2 items of Media coverage

  Press/Media

• Combination of Chemo and Immunotherapy is Shown to Work Against Metastatic Bladder Cancer

  Matthew Galsky,

  15/05/20

  1 item of Media coverage

  Press/Media

• Mount Sinai: Combination of Chemo and Immunotherapy Is Shown to Work Against Metastatic Bladder Cancer

  Matthew Galsky,

  15/05/20

  1 item of Media coverage

  Press/Media

• Combination of chemo and immunotherapy is shown to work against metastatic bladder cancer

  Matthew Galsky,

  15/05/20

  2 items of Media coverage

  Press/Media

• Drug Combo Offers Hope Against Advanced Bladder Cancer.

  Matthew Galsky,

  14/05/20

  1 item of Media coverage

  Press/Media

• 6-month progression is strong survival surrogate in mHSPC

  William Oh

  14/05/20

  1 item of Media coverage

  Press/Media

• Combination of Chemo and Immunotherapy Is Shown to Work Against Metastatic Bladder Cancer

  Matthew Galsky,

  14/05/20

  1 item of Media coverage

  Press/Media

• How new agents may address NMIBC treatment challenges

  Matthew Galsky,

  24/04/20

  1 item of Media coverage

  Press/Media

• Immunotherapy After Chemo May Slow Metastatic Bladder Cancer Progression

  Matthew Galsky,

  16/04/20

  1 item of Media coverage

  Press/Media

• Immunotherapy after chemo may slow metastatic bladder cancer progression

  Matthew Galsky,

  15/04/20

  1 item of Media coverage

  Press/Media

• ‘Switch maintenance’ pembrolizumab may benefit patients with metastatic urothelial cancer

  Matthew Galsky,

  13/04/20

  1 item of Media coverage

  Press/Media

• Performance of prostate multiparametric MRI for prediction of prostate cancer extraprostatic ...

  Natasha Kyprianou & Peter Wiklund

  23/03/20

  1 item of Media coverage

  Press/Media

• Sovrin Shah Md

  Sovrin Shah

  23/02/20

  1 item of Media coverage

  Press/Media

• Deciphering immuno-oncology: Targeting cellular mechanisms of the tumor immune response

  Matthew Galsky,

  29/01/20

  1 item of Media coverage

  Press/Media

• "Urinary Incontinence Is Common, Often Treatable—But Hard To Discuss – Laura Landro "

  Ashutosh Tewari

  19/11/19

  1 item of Media coverage

  Press/Media

• Dr Kim Ucla Urology

  Jay Motola,

  13/10/19

  1 item of Media coverage

  Press/Media

• Mount Sinai Urology Fellowship

  Mantu Gupta,, Gerardo Fernandez, Sam Horng, Ashutosh Tewari & Sherwin Zargaroff

  8/10/19

  1 item of Media coverage

  Press/Media

• Dr Atalla Urology

  Reza Mehrazin,

  8/10/19

  1 item of Media coverage

  Press/Media

• Harvard Cancer Medicine And Hematology 2018

  Samir Parekh & Matthew Galsky,

  8/10/19

  1 item of Media coverage

  Press/Media

• "Annual Meeting Continues Moving Personalized Medicine to the Fore" - Audrey Sternberg

  William Oh

  8/10/19

  1 item of Media coverage

  Press/Media